Eckert & Ziegler Strahlen und Medizintechnik (EUZ) Ratios
Eckert & Ziegler Strahlen und Medizintechnik Ratios
CH:EUZ's free cash flow for Q2 2026 was $3.40M. For the 2026 fiscal year, CH:EUZ's free cash flow was decreased by $-4.24M and operating cash flow was $7.64M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.45 | 3.12 | 2.79 | 2.78 | 2.94 |
| Quick Ratio | 2.81 | 2.51 | 2.31 | 2.00 | 2.32 |
| Cash Ratio | 1.79 | 1.64 | 0.81 | 1.25 | 1.55 |
| Solvency Ratio | 0.28 | 0.20 | 0.18 | 0.20 | 0.28 |
| Operating Cash Flow Ratio | 0.84 | 0.92 | 0.56 | 0.52 | 0.56 |
| Short-Term Operating Cash Flow Coverage | 9.57 | 10.41 | 7.39 | 0.00 | 4.79 |
| Net Current Asset Value | $ 15.70M | $ 8.19M | $ 18.38M | $ -19.47M | $ 22.40M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.13 | 0.13 | 0.12 | 0.08 |
| Debt-to-Equity Ratio | 0.18 | 0.25 | 0.25 | 0.23 | 0.14 |
| Debt-to-Capital Ratio | 0.15 | 0.20 | 0.20 | 0.19 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.06 | 0.08 | 0.10 | 0.00 |
| Financial Leverage Ratio | 1.93 | 1.98 | 1.98 | 1.97 | 1.86 |
| Debt Service Coverage Ratio | 8.31 | 5.91 | 4.63 | 25.18 | 5.44 |
| Interest Coverage Ratio | 38.67 | 16.30 | 11.77 | 26.49 | 38.52 |
| Debt to Market Cap | 0.01 | 0.02 | 0.03 | 0.02 | 0.00 |
| Interest Debt Per Share | 0.75 | 0.94 | 0.97 | 0.82 | 0.45 |
| Net Debt to EBITDA | -0.91 | -0.81 | -0.20 | -0.57 | -1.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.19% | 48.39% | 47.28% | 48.04% | 50.48% |
| EBIT Margin | 24.06% | 22.50% | 18.81% | 21.16% | 26.12% |
| EBITDA Margin | 29.53% | 26.15% | 24.25% | 26.05% | 31.41% |
| Operating Profit Margin | 24.06% | 20.64% | 19.10% | 21.13% | 25.51% |
| Pretax Profit Margin | 23.33% | 19.73% | 17.19% | 20.16% | 25.71% |
| Net Profit Margin | 15.63% | 11.25% | 10.69% | 13.17% | 19.14% |
| Continuous Operations Profit Margin | 15.78% | 13.82% | 12.39% | 13.90% | 19.01% |
| Net Income Per EBT | 67.01% | 57.01% | 62.17% | 65.35% | 74.43% |
| EBT Per EBIT | 96.95% | 95.57% | 90.02% | 95.38% | 100.77% |
| Return on Assets (ROA) | 10.04% | 7.52% | 5.99% | 7.02% | 9.93% |
| Return on Equity (ROE) | 19.37% | 14.89% | 11.84% | 13.81% | 18.43% |
| Return on Capital Employed (ROCE) | 18.13% | 16.50% | 13.21% | 13.39% | 16.02% |
| Return on Invested Capital (ROIC) | 11.99% | 11.27% | 9.29% | 9.36% | 11.56% |
| Return on Tangible Assets | 11.08% | 8.47% | 6.67% | 9.15% | 12.06% |
| Earnings Yield | 5.11% | 3.59% | 3.18% | 3.04% | 1.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.47 | 5.62 | 5.19 | 5.54 | 4.75 |
| Payables Turnover | 17.57 | 16.11 | 22.11 | 13.85 | 16.85 |
| Inventory Turnover | 3.58 | 3.48 | 3.25 | 2.24 | 2.52 |
| Fixed Asset Turnover | 2.30 | 2.25 | 2.20 | 1.99 | 2.22 |
| Asset Turnover | 0.64 | 0.67 | 0.56 | 0.53 | 0.52 |
| Working Capital Turnover Ratio | 1.89 | 1.95 | 1.84 | 1.89 | 1.50 |
| Cash Conversion Cycle | 162.71 | 147.32 | 166.09 | 202.67 | 200.28 |
| Days of Sales Outstanding | 81.63 | 65.00 | 70.26 | 65.89 | 76.90 |
| Days of Inventory Outstanding | 101.85 | 104.98 | 112.34 | 163.14 | 145.04 |
| Days of Payables Outstanding | 20.77 | 22.66 | 16.51 | 26.36 | 21.66 |
| Operating Cycle | 183.48 | 169.98 | 182.60 | 229.04 | 221.94 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.97 | 1.06 | 0.75 | 0.55 | 0.55 |
| Free Cash Flow Per Share | 0.55 | 0.79 | 0.34 | 0.05 | 0.08 |
| Dividend Paid and CapEx Coverage Ratio | 1.66 | 3.65 | 1.28 | 0.83 | 0.89 |
| Capital Expenditure Coverage Ratio | 2.32 | 3.87 | 1.79 | 1.10 | 1.17 |
| Operating Cash Flow Coverage Ratio | 1.35 | 1.20 | 0.83 | 0.69 | 1.26 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.23 | 0.19 | 0.15 | 0.19 |
| Free Cash Flow Yield | 3.60% | 5.32% | 2.55% | 0.33% | 0.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.56 | 27.98 | 31.45 | 32.91 | 56.41 |
| Price-to-Sales (P/S) Ratio | 3.06 | 3.13 | 3.36 | 4.34 | 10.79 |
| Price-to-Book (P/B) Ratio | 3.79 | 4.15 | 3.72 | 4.54 | 10.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 27.76 | 18.78 | 39.17 | 304.17 | 389.54 |
| Price-to-Operating Cash Flow Ratio | 15.80 | 13.93 | 17.62 | 28.10 | 57.53 |
| Price-to-Earnings Growth (PEG) Ratio | 0.41 | 1.07 | -2.96 | -2.11 | 1.12 |
| Enterprise Value Multiple | 9.45 | 11.17 | 13.67 | 16.07 | 33.19 |
| Enterprise Value | 870.83M | 864.51M | 815.54M | 930.50M | 1.88B |
| EV to EBITDA | 9.45 | 11.17 | 13.67 | 16.07 | 33.19 |
| EV to Sales | 2.79 | 2.92 | 3.31 | 4.19 | 10.42 |
| EV to Free Cash Flow | 25.33 | 17.51 | 38.61 | 293.72 | 376.20 |
| EV to Operating Cash Flow | 14.42 | 12.99 | 17.37 | 27.13 | 55.56 |
| Tangible Book Value Per Share | 3.32 | 2.81 | 2.87 | 1.87 | 2.11 |
| Shareholders’ Equity Per Share | 4.02 | 3.57 | 3.56 | 3.40 | 3.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.32 | 0.30 | 0.28 | 0.30 | 0.25 |
| Revenue Per Share | 4.99 | 4.73 | 3.94 | 3.57 | 2.91 |
| Net Income Per Share | 0.78 | 0.53 | 0.42 | 0.47 | 0.56 |
| Tax Burden | 0.67 | 0.57 | 0.62 | 0.65 | 0.74 |
| Interest Burden | 0.97 | 0.88 | 0.91 | 0.95 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.09 | 0.09 | 0.06 | 0.06 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.23 | 1.63 | 1.54 | 1.15 | 0.98 |
Currency in EUR
